Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InscoBi
Seoul, South Koreainscobee.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
InscoBi is a South Korean biotechnology and medical device company that operates across diverse sectors including healthcare, smart grid technology, and telecommunications. In the life sciences space, the company focuses on the development of innovative treatments for hair loss and erectile dysfunction, as well as metabolic diseases like diabetes and obesity. Through its subsidiaries and partnerships, InscoBi is advancing a pipeline of peptide-based therapeutics and medical devices. The company is notably involved in the development of 'Balman', a functional hair care brand, and is pursuing clinical trials for its pharmaceutical candidates. InscoBi is publicly traded on the Korea Stock Exchange (KRX).
- Therapeutic areas
- EndocrinologyMen's HealthDermatology
- Modalities
- Small moleculePeptidesMedical Device
- Industry
- Biotech
Beyond the preview
Go deeper on InscoBi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InscoBi.